LSD derivatives, synthesis and method for treatment of diseases and disorders (US Patent 12331051)
Patent number: 12331051 Kind code: B2 Granted: 2025-06-17 Filed: 2023-06-26 Inventors: Hooshmand Sheshbaradaran (Toronto, CA); Scott Rudge (Boulder, CO, US); Abdi Ghaffari (Kingston, CA); Stefan Soderman (Drayton, CA); Petar Duspara (Mississauga, CA) Assignees: BETTERLIFE PHARMA INC. (Vancouver, CA) CPC: C07B 2200/07; C07B 2200/13; C07D 457/06; C07D 471/06
Abstract
LSD derivative compounds and polymorphs thereof, methods for their synthesis, compositions and treatment of diseases and
Showing a preview — retrieve the full document via the Exa API.
Powered by the Exa API